Sucampo Pharmaceuticals Provides Update on Anticipated Arbitration Decision
Other Sources for this Article
Sucampo Pharmaceuticals, Inc.
Silvia Taylor, 1-240-223-3718
staylor@sucampo.com
or
Kate
de Santis, 1-240-223-3834
kdesantis@sucampo.com
